Clinical efficacy of multi-antigen induced dendritic cell-cytokine induced killer cells combined wit

• 作 者: ChuanyinShi;XiaoxiaKou;YanSun;XijingYang;GuanxiQiao;QianZhang;YaoHuang;FupingZhou;JinweiHu;QiaolingYan;YuanxiuLu;MengchaoWu;QijunQian;
• 机 构: Department of Biotherapy, Eastern Hepatobiliary Surgical Hospital, Shanghai, China
• 出 处: 第七届全国生物治疗大会
• 发表日期: 2014年期

　　Clinical response and post-treatment survival of cholangiocarcinoma patients receiving immunotherapy with autologous dendritic cells (DCs) and cytokine-induced killer (CIK) cells stimulated with multiple tumor-associated antigens (TAA) were evaluated recently.Nine stage Ⅳ, three stage Ⅲ, and one stage Ⅱ patients were enrolled in autologous DC-CIK cell transfusion along with conventional chemotherapy.The overall survival and disease progression status were analyzed and compared with existing literature records.